![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Posts
;
The inimitable @efratdotan presenting on lessons learned in her amazing career in GI oncology so far @eaonc spring meeting! @jordanberlin5 @CathyEngMD
Inspiring advice from keynote speaker @efratdotan of @PennMedicine @LGHealth at our Spring 2025 Task Force on #CareerAdvancement Session: 1) have an open mind, 2) learn from failures, and 3) develop relationships with colleagues
Many thanks to the esteemed presenters and panelists who participated in this spring's Robert L. Comis, MD #TranslationalScience Symposium: @CharuAggarwalMD, @DocDustyD, Dr. Gad Getz @getz_lab, Dr. Barbara Burtness, & our excellent moderator Dr. David Mankoff!
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
39
Active Clinical Trials
1400
Participating Institutions
67
International Sites
21000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
